0.1010
0.0000
(0.00%)
At close: January 29 at 3:00:00 PM EST
Breakdown
TTM
Operating Cash Flow
6,718.9910
Investing Cash Flow
-2,089.6420
Financing Cash Flow
5,406.3850
End Cash Position
18,090.2610
Income Tax Paid Supplemental Data
-556.8400
Interest Paid Supplemental Data
-668.9270
Capital Expenditure
-2,063.0170
Issuance of Debt
-3,170.7000
Repayment of Debt
3,641.9570
Free Cash Flow
4,655.9740
-
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
CLCS Cell Source, Inc.
0.2815
-6.17%
ISCO International Stem Cell Corporation
0.1100
0.00%
RSPI RespireRx Pharmaceuticals Inc.
0.0024
0.00%
IMUC EOM Pharmaceuticals Holdings, Inc.
0.1600
0.00%
ARTH Arch Therapeutics, Inc.
0.1810
0.00%
ENZN Enzon Pharmaceuticals, Inc.
0.1500
+15.38%
PBLA Panbela Therapeutics, Inc.
0.3252
-14.40%
IGXT IntelGenx Technologies Corp.
0.1700
0.00%
RLMD Relmada Therapeutics, Inc.
0.3540
-2.88%
HCWB HCW Biologics Inc.
0.2748
+6.06%